Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOMARIN PHARMACEUTICAL INC Director's Dealing 2018

Feb 21, 2018

30583_dirs_2018-02-20_d749ecd3-2863-4460-9140-d27d0a438d10.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2017-12-14

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-12-14 Common Stock G 600 $0.00 Disposed 182201 Indirect

Footnotes

F1: On December 14, 2017, the reporting person gifted 600 shares to an educational institution.

F2: On January 2, 2018, the reporting person filed a Form 4 which inadvertently reported the gift as made from the reporting person and not from the reporting person's trust. This amendment corrects such error.